These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7517066)

  • 1. Recent developments in diagnosis and treatment of metastatic carcinoid tumours.
    De Vries EG; Kema IP; Slooff MJ; Verschueren RC; Kleibeuker JH; Mulder NH; Sleijfer DT; Willemse PH
    Scand J Gastroenterol Suppl; 1993; 200():87-93. PubMed ID: 7517066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Carcinoid tumors: current insights in biochemical and endocrine aspects, diagnosis and treatment].
    de Graeff A; Kooijman CD; Obertop H; Lips CJ
    Ned Tijdschr Geneeskd; 1992 Mar; 136(11):508-13. PubMed ID: 1372712
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of carcinoid tumors of the digestive tract].
    Votte A; Cattan D; Dupas JL
    Gastroenterol Clin Biol; 1995 Dec; 19(12):1031-42. PubMed ID: 8729416
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serotonin producing tumors (carcinoid tumors and carcinoid syndrome)].
    Shibusawa N; Mori M
    Nihon Rinsho; 2006 Sep; Suppl 3():324-7. PubMed ID: 17022556
    [No Abstract]   [Full Text] [Related]  

  • 5. Serotonin, catecholamines, histamine, and their metabolites in urine, platelets, and tumor tissue of patients with carcinoid tumors.
    Kema IP; de Vries EG; Slooff MJ; Biesma B; Muskiet FA
    Clin Chem; 1994 Jan; 40(1):86-95. PubMed ID: 7507008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers.
    Biesma B; Willemse PH; Mulder NH; Verschueren RC; Kema IP; de Bruijn HW; Postmus PE; Sleijfer DT; de Vries EG
    Br J Cancer; 1992 Nov; 66(5):850-5. PubMed ID: 1384643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dramatic response of a metastatic carcinoid tumour to a combination of interferon and octreotide.
    Joensuu H; Kätkä K; Kujari H
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):184-5. PubMed ID: 1371898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas.
    Bashir S; Gibril F; Ojeaburu JV; Asgharian B; Entsuah LK; Ferraro G; Crafa P; Bordi C; Jensen RT
    Aliment Pharmacol Ther; 2002 Jul; 16(7):1367-82. PubMed ID: 12144588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Carcinoid tumor with revealed by skin manifestation].
    Reichert S; Truchetet F; Cuny JF; Grandidier M
    Ann Dermatol Venereol; 1994; 121(6-7):485-8. PubMed ID: 7535513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival and nearly asymptomatic course of carcinoid tumour with multiple metastases (treated by surgery, chemotherapy, (90)Y-DOTATATE, and LAR octreotide analogue): a case report.
    Kałuzny M; Bolanowski M; Sukiennik-Kujawa M; Ponikowski P; Handkiewicz-Junak D; Jarzab B; Jawiarczyk A; Syrycka J
    Endokrynol Pol; 2009; 60(5):401-6. PubMed ID: 19885812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carcinoid tumors].
    Tóth M; Prónai L; Németh AM; Tulassay Z
    Orv Hetil; 2002 May; 143(19 Suppl):1087-92. PubMed ID: 12063867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-alpha 2b, with or without prior hepatic artery embolization: clinical response and survival in mid-gut carcinoid patients. The Norwegian carcinoid study.
    Jacobsen MB; Hanssen LE; Kolmannskog F; Schrumpf E; Vatn MH; Bergan A
    Scand J Gastroenterol; 1995 Aug; 30(8):789-96. PubMed ID: 7481548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of digestive system carcinoid tumors and carcinoid syndrome].
    Mondragón Sánchez RJ; Castillero Pinilla C; Saldívar Moreno C; Oñate Ocaña LF; Ruiz Molina JM; Aiello Crocifoglio V
    Rev Gastroenterol Mex; 1998; 63(4):204-10. PubMed ID: 10319670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of midgut carcinoids.
    Akerström G; Hellman P; Hessman O; Osmak L
    J Surg Oncol; 2005 Mar; 89(3):161-9. PubMed ID: 15719373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal carcinoids: characterization by site of origin and hormone production.
    Onaitis MW; Kirshbom PM; Hayward TZ; Quayle FJ; Feldman JM; Seigler HF; Tyler DS
    Ann Surg; 2000 Oct; 232(4):549-56. PubMed ID: 10998653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet serotonin 5-HT2A receptor binding in patients with carcinoid tumor.
    Spigset O; Kristoffersson A; Mjörndal T
    Scand J Clin Lab Invest; 2004; 64(1):3-8. PubMed ID: 15025423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoid tumors of the gastrointestinal tract.
    Ghevariya V; Malieckal A; Ghevariya N; Mazumder M; Anand S
    South Med J; 2009 Oct; 102(10):1032-40. PubMed ID: 19738517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoid tumors.
    Robertson RG; Geiger WJ; Davis NB
    Am Fam Physician; 2006 Aug; 74(3):429-34. PubMed ID: 16913162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver metastases of digestive endocrine tumours: natural history and response to medical treatment.
    Skinazi F; Zins M; Menu Y; Bernades P; Ruszniewski P
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):673-8. PubMed ID: 8853257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary serotonin in the diagnosis of carcinoid tumors.
    Feldman JM
    Clin Chem; 1986 May; 32(5):840-4. PubMed ID: 2421946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.